Vijaya Diagnostic Centre Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹255 Cr +26.2% YoYSee revenue, profit and what management said. You are viewing Q4 FY26.
VD

Vijaya Diagnostic Centre Ltd

Q4 FY26Healthcare Services

Vijaya Diagnostic Centre Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹219Cr
+26.6% YoY
+6.8% QoQ
Net profit
₹48Cr
+37.1% YoY
+11.6% QoQ
Margin
44%
+4 pp YoY
+2 pp QoQ

Vijaya Diagnostic Centre Ltd Q4 FY26 key numbers

Revenue
Pune expected to double revenue in next 3-5 years, with newer hubs targeting INR 12-15 crores revenue per center.

As stated in Vijaya Diagnostic Centre Ltd's Q4 FY26 earnings call transcript · published 18 Aug 2026. Reported figures, not investment advice.

Price₹1,504
Market cap₹14.3K Cr
P/E82.7

The short version

Expectation of strong revenue and volume growth driven by network expansion in existing and new geographies (Hyderabad, Pune, Bangalore, West Bengal, etc.). Vijaya Diagnostic Centre expects continued double-digit revenue growth, particularly driven by network expansion in Pune, West Bengal, and new hubs in Bangalore.

From Vijaya Diagnostic Centre Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Expectation of strong revenue and volume growth driven by network expansion in existing and new geographies (Hyderabad, Pune, Bangalore, West Bengal, etc.).
  • Hyderabad to sustain double-digit growth (~20%) in near term, with additional spokes opening and market share gains.
  • Pune expected to double revenue in next 3-5 years, with newer hubs targeting INR 12-15 crores revenue per center.
  • Bangalore hubs showing promising traction with centers nearing break-even; more hubs planned.
  • Continued double-digit growth in Peripheral Healthcare (PH) and wellness segments.
  • Focus on volume-driven growth rather than premiumization, with ~1-1.5% realization price hikes.
  • Genomics is a long-term growth area, with gradual build-up expected but no significant near-term revenue impact.

2 more points from Vijaya Diagnostic Centre Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Vijaya Diagnostic Centre Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • FY'26 capex outlay was INR 169 crores, including replacement capex.
  • FY'27 planned capex for new centers and an automated lab estimated at INR 140-150 crores (Page 5, 12, 17).
  • Capex includes 4-5 hubs, 10-12 spokes, with leases executed currently; further capex guidance to be revised quarterly as new opportunities arise (Page 7, 9, 17).
  • Additional INR 10-15 crores allocated for maintenance capex yearly (Page 18).
  • Expansion focus is organic growth; no immediate inorganic acquisitions, though management remains open if valuation and value-add are right (Page 9).
  • Flagship hub in Bannerghatta, Bangalore with advanced equipment (PET CT, wide bore MRI) planned to be operational in next few months (Page 9).

2 more points from Vijaya Diagnostic Centre Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Vijaya Diagnostic Centre Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • Vijaya Diagnostic Centre has been catering to a few large corporates for the last couple of years.
  • Despite the presence of many aggregators and price-sensitive corporates causing some churn, the company has continuously received orders from large corporates over the past 2-3 years.
  • The company sees ongoing continuous orders and repeat business from large corporates.

2 more points from Vijaya Diagnostic Centre Ltd's call on order book

Create a free account to keep reading this call

Vijaya Diagnostic Centre Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Vijaya Diagnostic Centre Ltd Q4 FY26 results — key figures

Vijaya Diagnostic Centre Ltd Q4 FY26 reported results vs Q4 FY25, ₹ crore
₹ CrQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue219173+26.6%205+6.8%
Operating profit (EBITDA)9669+39.1%86+11.6%
Operating margin44%40%+4 pp42%+2 pp
Profit before tax6447+36.2%58+10.3%
Net profit (PAT)4835+37.1%43+11.6%
EPS (₹)4.663.40+37.1%4.20+11%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹255 Cr, net profit ₹59 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Healthcare Services this season

  • Suven Life Sciences (Q4 FY26)

    The provided pages of the investor presentation do not report any revenue, sales, or volume figures for the quarter. Key investor presentation takeaways from Su

  • Invicta Diagnostic (Q4 FY26)

    Invicta Diagnostic Limited is deploying IPO funds (INR 21 crores raised) primarily towards: . Key concall takeaways from Invicta Diagnostic's Q4 FY26 earnings…

  • KMC Speciality (Q4 FY26)

    Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) . Key concall takeaways from KMC Speciality Hospitals…

  • Star Imaging (Q4 FY26)

    Capex planned for FY27 is around INR 20 to 25 crores, mainly towards new centres and equipment. Key concall takeaways from Star Imaging's Q4 FY26 earnings call…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Vijaya Diagnostic Centre Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Vijaya Diagnostic Centre Ltd Q4 FY26 results?

Expectation of strong revenue and volume growth driven by network expansion in existing and new geographies (Hyderabad, Pune, Bangalore, West Bengal, etc.). Vijaya Diagnostic Centre expects continued double-digit revenue growth, particularly driven by network expansion in Pune, West Bengal, and new hubs in Bangalore.

What is Vijaya Diagnostic Centre Ltd share price analysis?

Vijaya Diagnostic Centre Ltd currently shows a neutral. The stock trades at a P/E of 82.7 with a market cap of ₹14,313 Cr. Investors should review the full earnings analysis for detailed insights.

Is Vijaya Diagnostic Centre Ltd planning capital expenditure?

FY'26 capex outlay was INR 169 crores, including replacement capex.

Keep Vijaya Diagnostic Centre Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.